Search Results for "SSRIs"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for SSRIs. Results 21 to 26 of 26 total matches.
Comparison Table: Triptans for Migraine (online only)
The Medical Letter on Drugs and Therapeutics • Jun 12, 2023 (Issue 1678)
of serotonin syndrome reported with SSRIs and SNRIs, but risk is likely low8
Other Drug Interactions CYP3A4 ...
View the Comparison Table: Triptans for Migraine
Med Lett Drugs Ther. 2023 Jun 12;65(1678):e97-9 doi:10.58347/tml.2023.1678b | Show Introduction Hide Introduction
A Fixed-Dose Combination of Meloxicam and Rizatriptan (Symbravo) for Migraine
The Medical Letter on Drugs and Therapeutics • Apr 28, 2025 (Issue 1727)
has been reported
with coadministration of triptans and selective
serotonin reuptake inhibitors (SSRIs ...
The FDA has approved Symbravo (Axsome), an oral
fixed-dose combination of the nonsteroidal anti-inflammatory
drug (NSAID) meloxicam and the
5-HT1B/1D receptor agonist (triptan) rizatriptan (Maxalt,
and generics), for acute treatment of migraine with or
without aura in adults. It is the second combination
of an NSAID and a triptan to be approved for migraine
treatment. An oral fixed-dose combination of
sumatriptan and naproxen (Treximet, and generics) is
approved for use in patients ≥12 years old.
Med Lett Drugs Ther. 2025 Apr 28;67(1727):68-70 doi:10.58347/tml.2025.1727b | Show Introduction Hide Introduction
Drugs for Cognitive Loss and Dementia
The Medical Letter on Drugs and Therapeutics • Aug 22, 2022 (Issue 1657)
in a total of 692
patients with dementia found that the selective
serotonin reuptake inhibitors (SSRIs ...
Alzheimer's disease (AD) is the most common
cause of dementia, but cognitive decline is also
associated with other neurological conditions such
as Parkinson's disease, dementia with Lewy bodies,
vascular dementia, and frontotemporal dementia.
Drugs for Opioid Use Disorder
The Medical Letter on Drugs and Therapeutics • Sep 04, 2023 (Issue 1684)
of methadone with selective
serotonin reuptake inhibitors (SSRIs), serotonin and
norepinephrine reuptake ...
Opioid use disorder is a chronic, relapsing disease with
physical and psychiatric components. It is associated
with economic hardship, social isolation, incarceration,
increased rates of blood-borne infections such as HIV
and viral hepatitis, adverse pregnancy outcomes, and
increased mortality. According to the NIH, there were
80,411 deaths involving an opioid in the US in 2021,
more than in any previous year. Several guidelines on
the management of opioid use disorder are available;
all recommend maintenance pharmacotherapy as the
standard of care.
Med Lett Drugs Ther. 2023 Sep 4;65(1684):137-44 doi:10.58347/tml.2023.1684a | Show Introduction Hide Introduction
Drugs for Irritable Bowel Syndrome
The Medical Letter on Drugs and Therapeutics • Feb 03, 2025 (Issue 1721)
inhibitors (SSRIs) have
been variable; they are generally not recommended for
treatment of IBS.1-3,23 ...
Irritable bowel syndrome (IBS) is a common disorder
characterized by recurrent abdominal pain and altered
bowel habits, often accompanied by bloating. IBS
is classified by its predominant bowel symptom:
constipation (IBS-C), diarrhea (IBS-D), mixed type
(IBS-M), or unclassified (IBS-U). Since the exact cause
of IBS is unknown, the goal of treatment is symptom
control. Some over-the-counter (OTC) products and
prescription drugs for IBS are listed in Tables 1-4. The
safety of these drugs during pregnancy and lactation
is described in Table 5 (online only).
Med Lett Drugs Ther. 2025 Feb 3;67(1721):17-24 doi:10.58347/tml.2025.1721a | Show Introduction Hide Introduction
Drugs for Hypothyroidism
The Medical Letter on Drugs and Therapeutics • Feb 20, 2023 (Issue 1670)
function
SSRIs Possible increased
LT4 requirements
Unknown Monitor thyroid function during and after ...
Primary hypothyroidism is usually the result of
Hashimoto's (autoimmune) thyroiditis, thyroidectomy,
or radioactive iodine therapy. Treatment of
hypothyroidism with replacement doses of thyroid
hormone is usually lifelong. Levothyroxine (LT4;
synthetic thyroxine; Synthroid, and others) is the drug
of choice.1
Med Lett Drugs Ther. 2023 Feb 20;65(1670):25-9 doi:10.58347/tml.2023.1670a | Show Introduction Hide Introduction